Last reviewed · How we verify
NCT03929822
Can Contrast-Enhanced Spectral Mammography Improve the Accuracy of a Diagnosis
trial testing Contrast-Enhanced Spectral Mammography in Breast Screening in 32 participants. Terminated before completion.
19 January 2023
Quick facts
| Lead sponsor | Memorial Sloan Kettering Cancer Center |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 32 |
| Start date | 23 April 2019 |
| Primary completion | 19 January 2023 |
| Estimated completion | 19 January 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Contrast-Enhanced Spectral Mammography
Conditions studied
- Breast Screening — all drugs for Breast Screening →
Sponsor
Memorial Sloan Kettering Cancer Center — full company profile →
Who can join
30 and older, female only, with Breast Screening. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to test whether contrast-enhanced spectral mammography (CESM) may be able to reduce the number of unnecessary biopsies in women whose screening mammograms had abnormal findings.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03929822
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Screening
Currently open trials in the same condition.
- NCT06636539 — Prospective Case Collection Study of Contrast-Enhanced Mammography Imaging Acquired on a New Investigational Device · NA · recruiting
- NCT03672331 — My Personalized Breast Screening · NA · active not recruiting
- NCT03233191 — Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer · Phase 3 · active not recruiting
Other Memorial Sloan Kettering Cancer Center trials
Trials by the same sponsor.
- NCT07566377 — Cord Blood Transplantation in Children and Young Adults With Blood Cancer · Phase 2 · recruiting
- NCT07507643 — A Study of Methylprednisolone in People Having Liver Surgery · Phase 3 · recruiting
- NCT07483307 — A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer · Phase 2 · recruiting
- NCT07459673 — HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term · Phase 2 · recruiting
- NCT07449195 — A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03929822 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center
- Last refreshed: 20 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03929822.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing